That is essential, due to the fact that the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. To put it simply, we need to understand how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error procedure (tech stocks). And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're developed to do. This was a breakthrough practically no one discovered. However it's going to have profound ramifications for curing disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be plenty of investment opportunities in this area, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown predictions 2021). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it pulled back maybe significantly before going higher - exponential tech investor. I have actually been covering bitcoin for a very long time now. One of the very first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were primarily informing readers. However that's not the big concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. white house. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are numerous excellent private companies on the brink of hitting the general public markets And I have actually been working on a new way for you to invest even before these business go public.
This opportunity has been constructing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to book your spot for complimentary.
Emma Walsh here, handling editor of the Diary. Routine Journal readers know that tech isn't our normal beat (biotech stocks jeff brown). And when it comes to tech investing, we leave it to the professionals. Luckily, we have numerous such professionals in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing professionals we understand (exponential growth). In truth, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the big photo and forecast what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing exponential growth and producing incredible chances for financiers. I want to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. jeff brown biotech stock. But despite what numerous readers may think, this is a pattern that's simply getting started. Although the COVID-19 pandemic interfered with supply chains in 2015, an excellent 250 million 5G-enabled gadgets were still offered.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (toxic tech 5 tech darlings). Losing two months of manufacturing and sales actually impacts how many 5G gadgets are sold in the calendar year. When you think about all of that, offering 250 million units is exceptional. More significantly, the hold-ups triggered by the pandemic produced a heap of bottled-up demand. And that need is now going to be pushed into 2021. In truth, I anticipate that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown stock predictions. Which's not my only 5G forecast When I've spoken about 5G in the past, I've described its three various phases.
In Stage 2, 5G devices go on sale. 5G phones and other products begin to reach customers. And in Stage Three, 5G services start to be provided (jeff brown stock predictions). That's when we begin to see applications operating on 5G networks. Think about things like massive multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Stage 3 by this summer. This begins something of a virtuous cycle: Most individuals don't really appreciate the technology. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In fact, 5G is going to open a suite of extraordinary applications: self-driving automobiles, the Internet of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment opportunities moving forward will be huge. Stepping away from 5G, the next crucial technology I predict in 2021 is CRISPR hereditary modifying. CRISPR stands for "clustered frequently interspaced brief palindromic repeat." It's a mouthful. However it is among the most interesting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software.
The program can crash or not function correctly. CRISPR utilizes a similar idea but with our genetic code. "Typos" in our genome can cause disease. CRISPR can fix these "typos." For many years, CRISPR was primarily a niche innovation that wasn't well comprehended. And during that time, there were truly only 3 business operating in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're dealing with diseases and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and providing incredible returns. This entire industry is effectively a greenfield chance.
There's space for lots of companies to exist in this area. first lady. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or three more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing incredible things happening at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its latest Alpha, Fold software can precisely predict the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is necessary due to the fact that the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental procedure. However now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to produce drugs that do what they're created to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but numerous drug therapies produced using this technology. This was among those breakthroughs that practically no one discovered. However it's going to have profound ramifications for curing disease. And, obviously, there will be plenty of investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it pulled back perhaps substantially before going greater. I have actually been covering bitcoin for a very long time now. One of the very first research study reports I ever released was on bitcoin - korean actress. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anybody who followed my suggestion. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
But nobody is asking that question any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. jeff bezos. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another benefit prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the info is up to date as of February 2021, but we might not individually validate this claim. Provided Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this moment. Brown is best known for his sage-like ability to pick winning technology stocks. He invested more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience provides him an exceptional point of view on the market. He's constantly on the hunt for brand-new opportunities, and he shares a number of his finest picks in the Future Report.
That's high appreciation, however it's not ridiculously reasoned. Brown has an excellent track record as a stock-picker, and he successfully anticipated a few of the greatest economic events of the past 20 years. Although he doesn't appear to release his choices to the general public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it best every time, but Jeff Brown's precise forecasts have actually earned him legions of devoted followers. That says a lot about his ability. The Near Future Report is published by Brownstone Research, a prominent financial research publisher. Brownstone Research offers a number of research services with a wide array of expertises - jeff brown top biotech 2020.
The business is likewise connected with Bonner & Partners, another well-respected research study publisher - black sea. On its site, Brownstone states its objective is to supply retail financiers with professional-grade research: "For too long, the best investment research study has not been available to specific investors. It has actually been usually reserved for financial investment banks, hedge funds, private equity, and high-net-worth clients. last year. The mission of Brownstone Research study is to make that sort of proprietary research available to any investors aiming to acquire an edge in the markets. The goal is easy to provide special and rewarding investment research study discovered no place else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also serves as the company's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of constant success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a household name throughout many of America. If you know even a bit about the market, you understand that he has a reputation as a King Midas of sorts. future report. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In reality, Brown thinks S.A.V. korean actress. might be "the biggest pattern of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding 2 advanced innovations: artificial intelligence and electrical cars and trucks. Musk hopes the mix will help him develop the very first fully-autonomous, self-driving cars and trucks ever. It's nothing except the vehicle market's Holy Grail. As you know, electrical cars and self-driving vehicle stocks have been huge this year, but the Wall Street machine has been huge on hype without much tangible outcome. Despite an extreme boost in competition over the past few years, Brown still thinks Musk has the very best chance of putting all of it together.
tech might be the magic string that ties it all together. S.A.V. represents Shared Autonomous Car, and it could be the future of transportation. Essentially, this innovation would permit you to lease your vehicle as an autonomous, self-driving taxi when you're not using it. You just leave the car and press a button on an app that tells the automobile to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your car shuttles ride-sharers around town. Most importantly, you get to keep a hefty chunk of the earnings. It sounds insane, but it might be closed than you believe.